Baycol


Also found in: Dictionary, Thesaurus.
Related to Baycol: Cerivastatin sodium, Lipobay

Baycol®

Cerivastatin Vascular disease A cholesterol-lowering, HMG-CoA reductase inhibitor–statin–for managing hypercholesterolemia and mixed dyslipidemia–it ↑ HDL-C by 4% and ↓ LDL-C by 36%. It was withdrawn fronm the market in mid-200/. See Statin.
References in periodicals archive ?
An estimated 700,000 patients took Baycol after it was approved in 1997 and before Bayer Corp.
Baycol, one of the world's most popular cholesterol-lowering drugs, was linked to 31 deaths in the United States from rhabdomyolysis, a side effect involving destruction of muscle cells, according to the U.
Like Baycol (cerivastatin), Crestor is one of a class of drugs called statins, used in patients who have high cholesterol levels and are at risk for atherosclerosis--a hardening or thickening of the arteries.
And users of Rezulin, Baycol, Propulsid, Duract, and several drugs linked in hundreds of deaths before the drugs were "voluntarily" withdrawn by their manufacturers will likely encounter the same obstacle in states with shield laws.
In the current Baycol litigation, the focus is primarily on the coprescription of Baycol and gemfibrozil for patients with severe cholesterol abnormalities and on the use of a higher strength of Baycol (0.
Once rigorous studies revealed the unacceptable risk, Baycol got buried promptly, Strom says in a JAMA article that Bayer submitted to the journal.
Upon withdrawing Baycol, Bayer said it would have to review its long-term commitment to remaining in the pharmaceutical business.
Bayer is the manufacturer of cerivastatin, an HMG-CoA reductase inhibitor marketed as Baycol in the United States.
Keller Rohrback, with offices in Seattle, Phoenix, New York, and Santa Barbara, has successfully represented hundreds of clients injured by prescription drugs such as Fen-Phen, Baycol, and Vioxx.
The Second Amended Complaint in this Litigation alleged that from August 4, 2000 to August 8, 2001, Defendants publicly misrepresented the prospects for Bayer's cholesterol-lowering drug, Baycol, while failing to disclose serious health risks, which led Bayer to withdraw Baycol on August 8, 2001.
Such an approach might mean that drugs that have been "voluntarily" recalled in recent years--such as Rezulin, Baycol, and fen-phen, to name only a few--would never have had the chance to become killers.
Health--Consumer and business-to-business by specific ailment (Rezulin, a diabetic drug removed from the market; Baycol, a cholesterol drug; and Fen-Phen, diet and nutrition).